Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xiidra
Pharma
Bausch + Lomb scoops up Novartis' dry eye med Xiidra for $2.5B
The deal also includes two other eye meds in development and rights to Novartis' AcuStream delivery tech in dry eye indications.
Zoey Becker
Jun 30, 2023 10:05am
Novartis targets Xiidra in eye disease asset sale: Bloomberg
Mar 14, 2023 10:22am
Lumenis taps 'This Is Us' star Mandy Moore for dry eye DTC spot
Feb 14, 2022 8:20am
Novartis bags option to buy developer of eye drug delivery tech
Nov 16, 2021 9:30am
In a first, FDA approves nasal spray to treat dry eye disease
Oct 19, 2021 7:40am
AbbVie puts 17-year-old Restasis brand back on TV
Apr 26, 2021 8:35am
